Research focused especially on some specific problems of some diseases, e.g. new drugs for reducing transfusion burden in beta-thalassemia or reducing the rate of vaso-occlusive crises in sickle cell ...

Erythroblasts possess unique characteristics as they undergo differentiation from hematopoietic stem cells. During terminal erythropoiesis, these cells incorporate large amounts of iron in order to ...

A systematic review and meta-analysis identified factors contributing to post-kidney transplant anemia and the effect of erythropoietin-stimulating agents (ESAs).

Severe erythrocytosis may increase the risk of thromboembolic events or hyperviscosity syndrome. Monitor Hgb before each dose for the first 5 doses, or longer if values are unstable, and ...

Merck , known as MSD outside of the United States and Canada, today announced that new clinical and outcomes research data will be presented at the American College of Cardiology's Annual Scientific ...

as it has been linked to increased haemoglobin levels that may lead to high levels of red blood cells (erythrocytosis) that could raise the risk of clotting and other side effects. In addition to ...